SCHEMBL6971603

SCHEMBL6971603

O=C(O)C1(c2cccc(Cl)c2)OCC(c2ccccc2)(c2ccccc2)CO1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA1 P02708 7/20 0.40
CHRNB1 P11230 7/20 0.40
CHRNB2 P17787 7/20 0.40
SLC6A2 P23975 7/20 0.40
CHRNB4 P30926 7/20 0.40
CHRNA3 P32297 7/20 0.40
CHRNA4 P43681 7/20 0.40
SLC6A3 Q01959 7/20 0.40
SLC6A4 P31645 6/20 0.40
CHRNG P07510 5/20 0.40
CHRND Q07001 5/20 0.40
HSD11B1 P28845 1/20 0.40
HCAR3 P49019 1/20 0.40
HCAR2 Q8TDS4 1/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
LMNA P02545 2/20 0.40
MAPT P10636 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6967893 0.85 CNR1 (0.40) HSD11B1KMT2AMAPTALDH1A1
SCHEMBL20592907 0.84 HSD11B1 (0.43) CHRNA1CHRNB1CHRNB2SLC6A2CHRNB4
SCHEMBL6981777 0.84 AKR1C1 (0.41) MEN1KMT2ALMNAHTTALDH1A1
SCHEMBL6973280 0.84 SLC6A2 (0.37) CHRNA1CHRNB1CHRNB2SLC6A2CHRNB4
SCHEMBL6982866 0.82 OPRM1 (0.41) CHRNA1CHRNB1CHRNB2SLC6A2CHRNB4
SCHEMBL377756 0.80 MAPK1 (0.40) CHRNA1CHRNB1CHRNB2SLC6A2CHRNB4
SCHEMBL6982594 0.76 HSD11B1 (0.39) CHRNA1CHRNB1CHRNB2SLC6A2CHRNB4
SCHEMBL6978477 0.76 LMNA (0.39) CHRNA1CHRNB1CHRNB2SLC6A2CHRNB4
SCHEMBL6984599 0.74 RXRA (0.53) NPC1RAB9ALMNAKDM4EALDH1A1
SCHEMBL7137847 0.74 LMNA (0.42) HCAR3HCAR2MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098893-B1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed